ArticleFrontiers in bioengineering and biotechnology2023

Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica.

Xinglong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.